发育期维生素D与孤独症谱系障碍:斯德哥尔摩青年队列研究
该研究基于瑞典斯德哥尔摩青年登记队列,检测母亲孕期和新生儿干血样本中总25-羟维生素D浓度,分析其与孤独症谱系障碍(ASD)风险的关联。结果显示,在 Nordic 出生母亲中,孕约11周25OHD不足与ASD风险升高相关,新生儿25OHD低于25 nmol/L也与ASD风险升高相关,且同胞匹配分析提示关联不太可能由家族混杂导致。
要点
- 在 Nordic 出生母亲中,孕约11周25OHD不足(25-<50 nmol/L)与ASD风险升高相关。
- 新生儿25OHD <25 nmol/L与ASD风险升高相关(OR 1.33,95%CI 1.02-1.75)。
- 母体与新生儿25OHD均低于中位数时,ASD风险升高(OR 1.75,95%CI 1.08-2.86)。
核心结论
- 早期生命维生素D浓度可能与包括ASD在内的神经发育障碍风险升高相关。
研究设计与样本
- 研究样本来自瑞典斯德哥尔摩青年登记队列,采用液相色谱串联质谱法检测母体和新生儿生物样本中总25OHD浓度。
- 母体样本包括449例ASD病例和574例对照,新生儿样本包括1399例ASD病例和1607例对照。
- 配对母体-新生儿样本包括340例ASD病例和426例对照。
主要发现
- 在总体样本中,母体25OHD与儿童ASD无关联。
- 在 Nordic 出生母亲中,孕约11周25OHD不足(25-<50 nmol/L)与ASD风险升高相关(OR 1.58,95%CI 1.00-2.49),参照为25OHD充足(≥50 nmol/L)。
- 新生儿25OHD <25 nmol/L与ASD风险升高相关(OR 1.33,95%CI 1.02-1.75),参照为25OHD ≥50 nmol/L。
- 同胞匹配对照分析提示这些关联不太可能由家族混杂导致。
- 母体与新生儿25OHD均低于中位数时,ASD风险升高(OR 1.75,95%CI 1.08-2.86),参照为两者均低于中位数。
临床怎么用
- 临床可关注孕期和新生儿期维生素D水平,尤其对Nordic出生母亲所生子女的ASD风险评估。
- 对25OHD不足的孕妇和新生儿,可考虑监测和适当干预,但需结合个体情况。
局限性
- 原文未明确报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Animal studies indicate that early life vitamin D is crucial for proper neurodevelopment. Few studies have examined whether maternal and neonatal vitamin D concentrations influence risk of autism spectrum disorders (ASD). Participants were sampled from the Stockholm Youth Cohort, a register-based cohort in Sweden. Concentrations of total 25-hydroxyvitamin D (25OHD) were assessed from maternal and neonatal biosamples using a highly sensitive liquid chromatography tandem mass spectrometry method. The maternal sample consisted of 449 ASD cases and 574 controls, the neonatal sample: 1399 ASD cases and 1607 controls; and the paired maternal-neonatal sample: 340 ASD cases and 426 controls. Maternal 25OHD was not associated with child ASD in the overall sample. However, in Nordic-born mothers, maternal 25OHD insufficiency (25 - <50 nmol/L) at ~11 weeks gestation was associated with 1.58 times higher odds of ASD (95% CI: 1.00, 2.49) as compared with 25OHD sufficiency (≥50 nmol/L). Neonatal 25OHD < 25 nmol/L was associated with 1.33 times higher odds of ASD (95% CI: 1.02, 1.75) as compared with 25OHD ≥ 50 nmol/L. Sibling-matched control analyses indicated these associations were not likely due to familial confounding. Children with both maternal 25OHD and neonatal 25OHD below the median had 1.75 (95% CI: 1.08, 2.86) times the odds of ASD compared with children with maternal and neonatal 25OHD both below the median. Our results are consistent with an increasing body of evidence suggesting that vitamin D concentrations in early life may be associated with increased risk of neurodevelopmental disorders including ASD.
引用
- Lee BK, Eyles DW, Magnusson C, et al. Developmental vitamin D and autism spectrum disorders: findings from the Stockholm Youth Cohort. Mol Psychiatry. 2019. PMID: 31695167. doi:10.1038/s41380-019-0578-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。